These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


853 related items for PubMed ID: 25845772

  • 21. Microemulsion for topical delivery of fenoprofen calcium: in vitro and in vivo evaluation.
    Farghaly DA, Aboelwafa AA, Hamza MY, Mohamed MI.
    J Liposome Res; 2018 Jun; 28(2):126-136. PubMed ID: 28081643
    [Abstract] [Full Text] [Related]

  • 22. Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein.
    Yoo JH, Shanmugam S, Thapa P, Lee ES, Balakrishnan P, Baskaran R, Yoon SK, Choi HG, Yong CS, Yoo BK, Han K.
    Arch Pharm Res; 2010 Mar; 33(3):417-26. PubMed ID: 20361307
    [Abstract] [Full Text] [Related]

  • 23. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
    Hussain A, Singh VK, Singh OP, Shafaat K, Kumar S, Ahmad FJ.
    Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
    [Abstract] [Full Text] [Related]

  • 24. Microemulsion loaded hydrogel as a promising vehicle for dermal delivery of the antifungal sertaconazole: design, optimization and ex vivo evaluation.
    Radwan SAA, ElMeshad AN, Shoukri RA.
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1351-1365. PubMed ID: 28420288
    [Abstract] [Full Text] [Related]

  • 25. Formulation of microemulsion systems for dermal delivery of silymarin.
    Panapisal V, Charoensri S, Tantituvanont A.
    AAPS PharmSciTech; 2012 Jun; 13(2):389-99. PubMed ID: 22350738
    [Abstract] [Full Text] [Related]

  • 26. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
    Cirri M, Mura P, Mora PC.
    Int J Pharm; 2007 Aug 01; 340(1-2):84-91. PubMed ID: 17531411
    [Abstract] [Full Text] [Related]

  • 27. Microemulsions based on TPGS and isostearic acid for imiquimod formulation and skin delivery.
    Pescina S, Garrastazu G, Del Favero E, Rondelli V, Cantù L, Padula C, Santi P, Nicoli S.
    Eur J Pharm Sci; 2018 Dec 01; 125():223-231. PubMed ID: 30316975
    [Abstract] [Full Text] [Related]

  • 28. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N, Dora CP, Singh C, Paidi SR, Kumar V, Sobhia ME, Suresh S.
    Carbohydr Polym; 2015 Dec 10; 134():547-56. PubMed ID: 26428157
    [Abstract] [Full Text] [Related]

  • 29. Methoxy poly (ethylene glycol)-b-poly (δ-valerolactone) copolymeric micelles for improved skin delivery of ketoconazole.
    Deng P, Teng F, Zhou F, Song Z, Meng N, Feng R.
    J Biomater Sci Polym Ed; 2017 Jan 10; 28(1):63-78. PubMed ID: 27691601
    [Abstract] [Full Text] [Related]

  • 30. Microencapsulation of a cyclodextrin complex of the UV filter, butyl methoxydibenzoylmethane: in vivo skin penetration studies.
    Scalia S, Coppi G, Iannuccelli V.
    J Pharm Biomed Anal; 2011 Jan 25; 54(2):345-50. PubMed ID: 20934293
    [Abstract] [Full Text] [Related]

  • 31. Effect of pH and complexation on transdermal permeation of gliquidone.
    Sridevi S, Diwan PV.
    Pharmazie; 2002 Sep 25; 57(9):632-4. PubMed ID: 12369452
    [Abstract] [Full Text] [Related]

  • 32. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam.
    Li F, Song S, Guo Y, Zhao Q, Zhang X, Pan W, Yang X.
    Drug Deliv; 2015 Sep 25; 22(4):487-98. PubMed ID: 24524289
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: effect of randomly methylated β-cyclodextrin.
    Mura P, Bragagni M, Mennini N, Cirri M, Maestrelli F.
    Int J Pharm; 2014 Nov 20; 475(1-2):306-14. PubMed ID: 25194352
    [Abstract] [Full Text] [Related]

  • 36. Development of microemulsions of suitable viscosity for cyclosporine skin delivery.
    Benigni M, Pescina S, Grimaudo MA, Padula C, Santi P, Nicoli S.
    Int J Pharm; 2018 Jul 10; 545(1-2):197-205. PubMed ID: 29698819
    [Abstract] [Full Text] [Related]

  • 37. Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
    Manta K, Papakyriakopoulou P, Chountoulesi M, Diamantis DA, Spaneas D, Vakali V, Naziris N, Chatziathanasiadou MV, Andreadelis I, Moschovou K, Athanasiadou I, Dallas P, Rekkas DM, Demetzos C, Colombo G, Banella S, Javornik U, Plavec J, Mavromoustakos T, Tzakos AG, Valsami G.
    Mol Pharm; 2020 Nov 02; 17(11):4241-4255. PubMed ID: 32986435
    [Abstract] [Full Text] [Related]

  • 38. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 02; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Microneedle-Assisted Percutaneous Delivery of a Tetramethylpyrazine-Loaded Microemulsion.
    Zu Q, Yu Y, Bi X, Zhang R, Di L.
    Molecules; 2017 Nov 21; 22(11):. PubMed ID: 29160824
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 43.